Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Cancer Survival Analysis

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...

Treatment Resistant Cancers

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...

Quality Assurance

Quality Assurance

Quality assurance is the overarching term used to describe the activities employed to ensure the proper performance of a system. These activities can be classified into three categories: quality control, quality assessment, and internal corrective measures. Typically, these activities work cyclically: quality control is performed before and during the analysis, while quality assessment occurs during and after the investigation. Internal corrective measures are implemented based on the findings...

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...

Cancer Prevention

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Cancer Frequencies and Screening in Individuals With Down Syndrome: A Comprehensive Nationwide Cross-Sectional Analysis.

JCO global oncology·2026

Same author

Social inequalities in return-to-work among colorectal cancer survivors in Germany.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2026

Same author

[The ACO Curriculum - Advanced Training Program in Surgical Oncology].

Zentralblatt fur Chirurgie·2026

Same author

Impact of comorbidity on patient reported outcome measures for men with localised prostate cancer.

BMC urology·2026

Same author

Social inequalities in cancer in Germany: a call to action.

Journal of cancer research and clinical oncology·2026

Same author

Patient-reported outcomes: active surveillance vs radical therapies in low-risk prostate cancer.

BJU international·2026

Search research articles

Related Experiment Video

Updated: Dec 24, 2025

Bioluminescence-Based Tumor Quantification Method for Monitoring Tumor Progression and Treatment Effects in Mouse Lymphoma Models

Bioluminescence-Based Tumor Quantification Method for Monitoring Tumor Progression and Treatment Effects in Mouse Lymphoma Models

Published on: July 7, 2016

Implementing quality metrics in European Cancer Centers (ECCs).

Ellen Griesshammer¹, Henning Adam², Nora Tabea Sibert²

¹German Cancer Society, Kuno-Fischer-Strasse 8, 14057, Berlin, Germany. griesshammer@krebsgesellschaft.de.

World Journal of Urology

|April 8, 2020

Summary

Certification by the German Cancer Society (DKG) is achievable for prostate cancer centers outside Germany (PCCoG). While challenging initially, meeting DKG criteria leads to improved indicators and patient numbers, though healthcare system differences require consideration.

Keywords:

Certification Health service research Quality assurance Quality indicators

More Related Videos

Development of Compendium for Esophageal Squamous Cell Carcinoma

Development of Compendium for Esophageal Squamous Cell Carcinoma

Published on: April 12, 2024

Construction of a Preclinical Multimodality Phantom Using Tissue-mimicking Materials for Quality Assurance in Tumor Size Measurement

Construction of a Preclinical Multimodality Phantom Using Tissue-mimicking Materials for Quality Assurance in Tumor Size Measurement

Published on: July 29, 2013

Related Experiment Videos

Last Updated: Dec 24, 2025

Bioluminescence-Based Tumor Quantification Method for Monitoring Tumor Progression and Treatment Effects in Mouse Lymphoma Models

Bioluminescence-Based Tumor Quantification Method for Monitoring Tumor Progression and Treatment Effects in Mouse Lymphoma Models

Published on: July 7, 2016

Development of Compendium for Esophageal Squamous Cell Carcinoma

Development of Compendium for Esophageal Squamous Cell Carcinoma

Published on: April 12, 2024

Construction of a Preclinical Multimodality Phantom Using Tissue-mimicking Materials for Quality Assurance in Tumor Size Measurement

Construction of a Preclinical Multimodality Phantom Using Tissue-mimicking Materials for Quality Assurance in Tumor Size Measurement

Published on: July 29, 2013

Area of Science:

Oncology
Healthcare Quality Improvement
International Healthcare Standards

Background:

German Cancer Society (DKG) certification extended to prostate cancer centers outside Germany (PCCoG) in 2014.
Certified PCCoG must meet the same stringent requirements as domestic German centers.
This study evaluates the initial experiences and performance indicators of the first nine certified PCCoG.

Purpose of the Study:

To report on the experiences of the first nine certified prostate cancer centers outside Germany (PCCoG).
To analyze and compare indicator results between certified PCCoG and German prostate cancer centers (PCC).
To assess the impact of DKG certification on quality indicators and patient numbers in PCCoG.

Main Methods:

Descriptive analysis of primary case distribution, indicator definitions, and patient numbers.
Comparative analysis of indicator results between 114 German PCC and 9 PCCoG certified for at least 3 years.
Statistical trend analysis using two-sided Cochran-Armitage tests to evaluate changes over time.

Main Results:

Both German PCC and certified PCCoG demonstrated a steady increase in primary cases and indicator fulfillment from 2015-2017.
PCCoG initially faced challenges with psycho-oncological services (POS) and social service counseling (SCC) requirements.
While POS fulfillment improved post-certification, SCC rates remained low in PCCoG due to differing healthcare system structures.

Conclusions:

DKG certification is attainable for PCCoG, requiring significant effort but leading to improved quality indicators and patient volumes.
Differences in healthcare systems necessitate adaptation of certification requirements for country-specific implementation.
Certified PCCoG show potential for quality enhancement, highlighting the value of international standardization efforts.